“…However, one study demonstrated the positivity of AI in 26.2% in a cohort of 42 MS patients, using a commercial kit of sandwich enzyme immunoassay (Test-Line Ltd, Clinical Diagnostics) different from the kit used for the two patients here [21]. In two previous studies of ON, with systematic screening for Lyme disease, four patients also had strong arguments in favor of isolated Lyme ON [6,7]. In the first study, 25 out of 440 patients with ON had positive Lyme serology and two of these patients had a positive specific AI [6], giving an overall prevalence of Lyme ON of 0.5%.…”